Lydia Torne

Partner at Latham & Watkins

Speaker

Lydia Torne advises clients in the life sciences industry on complex collaborations and licensing transactions, as well as UK regulatory compliance issues.

Lydia represents the full range of life sciences clients, including global pharmaceutical and medtech companies, leading biotechs, and academic institutions, on business-critical IP transactions involving:

• Licensing
• Collaborations
• Joint ventures and consortium agreements
• Commercialization and co-promotion agreements
• Corporate transactions, financings, and royalty monetizations

Lydia also assists life sciences clients in material regulatory compliance issues, including product classification, interactions with healthcare professionals, clinical trials, market access, supply chain requirements, marketing, and pharmacovigilance.

A recognized thought leader, Lydia regularly writes and speaks about the complexities of licensing transactions and digital health, including in The Lancet, Pharma Focus America, and Drug Discovery Today.